Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment.

Cancer biotherapy & radiopharmaceuticals - 1 Apr 2007

Ren Xiu-Bao, Yu Jin-Pu, Cao Shui, Ren Bao-Zhu, Li Hui, Liu Hong, Min Wei-Ping, Hao Xi-Shan

Abstract excerpt

OBJECTIVE: The traditional immunotherapy for patients with refractory metastatic solid tumors is limited because tumors induce immunosuppression. New treatment is, therefore, needed. The aim of this study was to evaluate the clinical efficacy of infusion of high-dose interleukin (IL)-2-activated allogeneic haploidentical peripheral blood stem cells (haplo-PBSCTs) on patients with an advanced stage of refractory...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Donors
Share to Hematopoietic Stem Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Interleukin-2

Share to Neoplasm Metastasis

Share to Th1 Cells

Share to Th2 Cells

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 17600469
DOI: 10.1089/cbr.2007.334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antitumor effect of large doses IL-2-activated HLA haploidentical peripheral blood stem cells on refractory metastatic solid tumor treatment.PMID 17600469Read ↗

The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study.Semantic proximity Read ↗

Impact of IL-2 and IL-2R SNPs on proliferation and tumor- killing activity of lymphokine-activated killer cells from healthy chinese blood donors.Semantic proximity Read ↗

Phenotypic characterization and anti-tumor effects of cytokine-induced killer cells derived from cord blood.Semantic proximity Read ↗

Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies.Semantic proximity Read ↗

Phenotypic and immunologic characteristics of docetaxel-mobilized peripheral blood stem cells in mice.Semantic proximity Read ↗

Effects of escalating doses of recombinant human interleukin-2 in correcting functional T-cell defects following autologous bone marrow transplantation for lymphomas and solid tumors.Semantic proximity Read ↗

High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy.Semantic proximity Read ↗

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: a pilot study.Semantic proximity Read ↗

Effectiveness of allogeneic CD3AK cells on transplanted human renal cell cancer in mice with severe combined immune deficiency.Semantic proximity Read ↗

Generation of cytotoxic T lymphocytes from peripheral blood.Semantic proximity Read ↗

Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates.Semantic proximity Read ↗

Effects of CD3McAb and rhIL-2 activated bone marrow on the killing and purging of leukemia cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.